| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DALE MICHAEL D | Chief Executive Officer | 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA | /s/ Mark Began, as attorney-in-fact for Michael Dale | 27 Feb 2026 | 0001172346 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Restricted Stock Units | Award | $0 | +98,000 | $0.000000 | 98,000 | 26 Feb 2026 | Common Stock | 98,000 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |
| F2 | All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. |